Document is current
Any future updates will be listed below
-
Authors
Dussupt, Vincent
Jensen, Jaime L.
Rosado, Angélica Peña
Donofrio, Marissa
Pflugheber, Jill
Mendez-Rivera, Letzibeth
Sankhala, Rajeshwer S.
Chen, Wei-Hung
Slike, Bonnie M.
Schmid, Annika
Tran, Ursula
Metzger, Lily
Peterson, Caroline E.
Pinto, Amelia K.
Vasan, Sandhya
Collins, Natalie D.
Farmer, Aaron
Michael, Nelson L.
Joyce, M. Gordon
Brien, James D.
Krebs, Shelly J.
-
Funding
Funding for this research was provided by:
National Institute of infectious (R01AI155983)
National Institute of Allergy and Infectious Diseases (R01AI155983)
National Institute of Allergy and Infectious Diseases (R01AI155983)
National Institute of Allergy and Infectious Diseases (R01AI155983)
- License Information
-
More Information
Article History
Received: 7 November 2025
Accepted: 2 April 2026
First Online: 14 April 2026
Competing interests
: V.D. (The Henry M. Jackson Foundation (HJF) for the advancement of Military Medicine) and S.J.K. (United States Government) are named inventors on US pending patent 18/866,371 “Immunogens and Vaccine Compositions Against Flavivirus” describing the design and use of flavivirus envelope DI-DIII flavivirus immunogens. All other authors declare no competing interests.
